Antioxidant effect of Carvedilol and metoprolol in congestive heart failure

被引:5
|
作者
Kukin, ML [1 ]
Kalman, J [1 ]
Charney, RH [1 ]
Levy, DK [1 ]
Buchholz-Varley, C [1 ]
Ocampo, ON [1 ]
Eng, C [1 ]
机构
[1] Mt Sinai Sch Med, Cardiovasc Inst, New York, NY USA
关键词
D O I
10.1016/S0735-1097(97)84526-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:189A / 189A
页数:1
相关论文
共 50 条
  • [31] Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure Carvedilol or Metoprolol Evaluation Study
    Froehlich, Hanna
    Zhao, Jingting
    Taeger, Tobias
    Cebola, Rita
    Schellberg, Dieter
    Katus, Hugo A.
    Grundtvig, Morten
    Hole, Torstein
    Atar, Dan
    Agewall, Stefan
    Frankenstein, Lutz
    CIRCULATION-HEART FAILURE, 2015, 8 (05) : 887 - 896
  • [32] Effects of carvedilol on heart rate dynamics in patients with congestive heart failure
    Ridha, M
    Mäkikallio, TH
    Lopera, G
    Pastor, J
    de Marchena, E
    Chakko, S
    Huikuri, HV
    Castellanos, A
    Myerburg, RJ
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2002, 7 (02) : 133 - 138
  • [34] The effect of the concomitant use of carvedilol and spironolactone in patients with mild to moderate congestive heart failure
    Yamada, T
    Shimonagata, T
    Kumagai, K
    Hirata, A
    Makino, N
    Kioka, H
    Fukunami, M
    CIRCULATION, 2002, 106 (19) : 353 - 353
  • [35] Effect of metoprolol CR XL in chronic heart failure:: Metoprolol CR XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
    Hjalmarson, Å
    Goldstein, S
    Fagerberg, B
    Wedel, H
    Waagstein, F
    Kjekshus, J
    Wikstrand, J
    Westergren, G
    Hässle, A
    Thimell, M
    El Allaf, D
    Vitovec, J
    Aldershvile, J
    Halinen, M
    Dietz, R
    Neuhaus, KL
    Janosi, A
    Thorgeirsson, G
    Dunselman, P
    Gullestad, L
    Kuch, J
    Herlitz, J
    Rickenbacher, P
    Ball, S
    Gottlieb, S
    Deedwania, P
    Vandenhoven, G
    Nováková, I
    Danker, S
    Lundström, M
    Meyer-Sabellek, W
    Balla, I
    Sveinsdottir, M
    Dorhout, B
    Hildebrandt, A
    Szczurko, I
    Larsson, C
    Bucher, E
    Scott, E
    Dwyer, D
    Julian, DG
    DeMets, DL
    Chatterjee, K
    Feyzi, J
    Lehto, S
    Kárpáti, P
    Motz, W
    Samuelsson, O
    Viersma, JW
    Andersson, B
    LANCET, 1999, 353 (9169): : 2001 - 2007
  • [36] Effectiveness of carvedilol alone versus carvedilol plus pimobendan for severe congestive heart failure
    Yoshikawa, T
    Baba, A
    Suzuki, M
    Yokozuka, H
    Okada, Y
    Nagami, K
    Takahashi, T
    Mitamura, H
    Ogawa, S
    Ogawa, S
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (12): : 1495 - +
  • [37] Clinical and hemodynamic efficacy of carvedilol in patients with congestive heart failure
    Tereschenko, SN
    Demidova, IV
    Borisov, NE
    Moiseev, NS
    KARDIOLOGIYA, 1998, 38 (02) : 43 - 46
  • [38] Population pharmacokinetics of carvedilol in pediatric patients with congestive heart failure
    Läer, S
    Albers, S
    Gupta, M
    Meibohm, B
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R144 - R144
  • [39] Population pharmacokinetics of carvedilol in pediatric patients with congestive heart failure
    Laer, S
    Albers, S
    Gupta, M
    Mir, TS
    Meibohm, B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P88 - P88
  • [40] Comparative effects of metoprolol and carvedilol on left ventricular function in heart failure
    Udelson, JE
    Antonopoulos, GV
    Berlin, JA
    Chittams, J
    Konstam, MA
    Packer, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 184A - 184A